Meanwhile, knockdown of or pharmacologically inhibiting NLRP3, neutralizing S100A9, can alleviate pyroptosis, ROS accumulation, and nuclear β-catenin in MDS, rendering restoration of colony-forming capacity and efficient hematopoiesis [176]. Here, NLRP3 is linked to myelodysplastic syndrome.